Iran Ends Visa-Free Entry for Indian Nationals from 22 November 2025

Iran has officially withdrawn visa-free entry for Indian nationals, enforcing a mandatory visa requirement for all ordinary passport holders from 22 November 2025. The decision follows a surge in human trafficking, fraudulent employment schemes and kidnapping incidents involving Indian citizens who were misled into travelling to Iran under false pretences.

Luke Littler Creates History as Youngest World No. 1 After Grand Slam Victory

Luke Littler has carved his name into sporting history by becoming the youngest-ever world number one in professional darts at just 18 years old. His emphatic 16–11 win over reigning world number one Luke Humphries in the Grand Slam of Darts 2025 final in Wolverhampton cemented his rapid ascent to the top of the PDC (Professional Darts Corporation) rankings.

Arunachalam Vellayan, Former Murugappa Group Chairman, Passes Away at 72

Arunachalam Vellayan, one of India’s most respected industrial leaders and a fourth-generation member of the Murugappa family, passed away at the age of 72 after a prolonged illness. Widely admired for his visionary leadership and ethics, Vellayan played a pivotal role in shaping the growth trajectory of the 125-year-old Murugappa Group, one of India’s largest diversified conglomerates.

India Sends First Jet Fuel Cargo to US West Coast

India has entered a new phase in its refined petroleum exports by dispatching its first-ever jet fuel cargo to the United States’ West Coast. The unprecedented shipment underscores India’s increasing prominence in global energy supply chains and reflects changing market dynamics triggered by refinery disruptions in the U.S.

AstraZeneca and Sun Pharma Partner to Market Hyperkalaemia Drug in India

AstraZeneca Pharma India and Sun Pharmaceutical Industries have announced a strategic partnership to widen access to Sodium Zirconium Cyclosilicate (SZC)—a key therapy for managing hyperkalaemia, a potentially life-threatening elevation of potassium levels often seen in chronic kidney disease (CKD) and heart failure (HF) patients. The agreement is aimed at strengthening national reach through a dual-brand expansion model.